Click to view a price quote on TEVA. Click to research the Drugs industry.
26
Dec
Archives
23
Dec
Ocular Therapeutix Hit by Subpoena, SEC Seeks Eye Pain Drug Documents
Federal securities regulators are asking questions about an Ocular Therapeutix eye pain product that was rejected by the FDA in
23
Dec
Could These 2 Biotech ‘Busted IPOs’ Be the Next Ignyta?
Click to view a price quote on RXDX. Click to research the Drugs industry.
23
Dec
Ocular Therapeutics Hit by Subpoena, SEC Seeks Eye Pain Drug Documents
Federal securities regulators are asking questions about an Ocular Therapeutics eye pain product that was rejected by the FDA in
22
Dec
Volume Slows Ahead of Christmas Holiday
Click to view a price quote on MARK. Click to research the Internet industry.
22
Dec
Flexion Therapeutics Promotes Scott Kelley to Chief Medical Officer
Scott Kelley has been appointed chief medical officer of Flexion Therapeutics (NASDAQ: FLXN). Kelley was previously vice president of medical
21
Dec
Biogen, Eisai Alzheimer’s Drug Fails First Test But Study Continues
The lead drug in a wide-ranging Alzheimer’s disease collaboration between Biogen and Eisai has flunked its first test, falling short
20
Dec
CRISPR Could Soon Charge into Hearing Loss Drug Race, New Study Suggests
Nearly 40 million Americans say they have trouble hearing for one reason or another. There are no drug treatments, just
20
Dec
Zimmer Biomet Hires Medtronic Exec Bryan Hanson for CEO Role
After a five-month search, Zimmer Biomet announced that medical device industry veteran Bryan Hanson is now the company’s top executive.
20
Dec